Adopted guidelines of care for the topical management of psoriasis from American and German guidelines

✍ Scribed by Ali A. Al Raddadi; Mohammad I. Fatani; Yasir H. Shaikh; Diamant Thaci; Abdullah A. Al Reshaid; Abdullah M. Al-Eisa; Walid A. Alghamdi; Hassan Y. Abdulfattah; Zohir M. Al Belbisi; Ali C. Atawi; Waleed A. Alajroush; Abdullah A. Al Fadly; Said I. El-Shamy; Sameer K. Zimmo; Abdullah A. Alqahtani; Majdy M. Abdulghani; Khaled M. Al Abod; Khaled M. Al Attas; Mohamad F. Al Ayouby; Mohammed S. Qari; Adel S. Al Ghanim

• Publisher: Elsevier
• Year: 2011
• Weight: 389 KB
• Volume: 15
• Category: Article
• ISSN: 2210-836X
• DOI: 10.1016/j.jssdds.2010.10.002

✦ Synopsis

Psoriasis is a chronic, noncontiguous, inflammatory, multisystem disease with predominantly skin and joint manifestations affecting approximately 2% of the population. There is a genetic predisposition to psoriasis and has tendency to wax and wane with flares related to systemic or environmental factors, including life stress events and infection.

Majority of patients with psoriasis have limited disease (5% body surface area involvement) and can be treated with topical agents, which generally provide a high efficacy-to-safety ratio.

To optimize the topical treatment of psoriasis in Saudi Arabia, the Saudi Society of Dermatology and Dermatologic surgery (SSDDS) have initiated a project to develop guidelines for the management of psoriasis. The guidelines are based on German and American one with subsequent discussion with experts in the field; they have been approved by a team of dermatology experts.